We are live on ! Find out more
IART icon

Integra LifeSciences

186 hedge funds and large institutions have $2.12B invested in Integra LifeSciences in 2015 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 78 increasing their positions, 58 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more funds holding in top 10

Funds holding in top 10: 15 (+4)

84% more call options, than puts

Call options by funds: $138K | Put options by funds: $75K

34% more repeat investments, than reductions

Existing positions increased: 78 | Existing positions reduced: 58

16% more capital invested

Capital invested by funds: $1.83B → $2.12B (+$294M)

8% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 26

2% less funds holding

Funds holding: 189186 (-3)

Holders
186
Holders Change
-3
Holders Change %
-1.59%
% of All Funds
4.88%
Holding in Top 10
5
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+400%
% of All Funds
0.13%
New
24
Increased
78
Reduced
58
Closed
26
Calls
$138K
Puts
$75K
Net Calls
+$63K
Net Calls Change
+$133K
Name Holding Trade Value Shares
Change
Change in
Stake
AAM
201
Azzad Asset Management
Virginia
-$295K -9,900 Closed
Asset Management One
202
Asset Management One
Japan
-$149K -5,040 Closed
SG Americas Securities
203
SG Americas Securities
New York
-$145K -4,868 Closed
QT
204
Quantbot Technologies
New York
-$90K -3,030 Closed
GS
205
GAM Systematic
United Kingdom
-$52K -1,762 Closed
W
206
Wealthfront
California
-$11K -374 Closed
IRS
207
Invictus RG (Singapore)
Singapore
-$11K -366 Closed
Barclays
208
Barclays
United Kingdom
-$9K -296 Closed
SIM
209
Sonora Investment Management
Arizona
-$3K -110 Closed
Simplex Trading
210
Simplex Trading
Illinois
-$1K -40 Closed
FNBT
211
FineMark National Bank & Trust
Florida
-$1K -38 Closed

IART Hedge Fund Activity: Q4 2015 in Review

186 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q4 2015, worth a combined $2.12B — up 16% from $1.83B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of IART and 24 opened new positions — a net loss of 2 holders — while 58 trimmed existing stakes and 78 added.

The largest buyer was Wells Fargo, adding an estimated $40.9M. The largest seller was Vaughan Nelson Investment Management, cutting an estimated $38.5M.

  • 186 institutional investors held Integra LifeSciences (IART) as of Q4 2015, down from 189 in Q3 2015.
  • Funds reported $2.12B of Integra LifeSciences stock for Q4 2015, up 16% quarter-over-quarter.
  • 24 funds opened new Integra LifeSciences positions in Q4 2015 and 26 closed out, a net change of -2 holders.
  • The largest Integra LifeSciences buyer in Q4 2015 was Wells Fargo, an estimated $40.9M added.
  • The largest Integra LifeSciences seller in Q4 2015 was Vaughan Nelson Investment Management, an estimated $38.5M sold.

Based on aggregated 13F filings for Q4 2015.